ClinicalTrials.gov
ClinicalTrials.gov Menu

Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy (ACCEPT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01192087
Recruitment Status : Unknown
Verified April 2013 by Heidelberg University.
Recruitment status was:  Recruiting
First Posted : August 31, 2010
Last Update Posted : April 24, 2013
Sponsor:
Collaborators:
Dept. of Radiation Oncology, INF 400, 69120 Heidelberg, Germany
University Hospital Heidelberg
Merck KGaA, Darmstadt, Germany
Information provided by:
Heidelberg University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2015
  Estimated Study Completion Date : July 2017
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):